Showing 2241-2250 of 7009 results for "".
The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy
https://reachmd.com/programs/medical-industry-feature/the-role-of-april-and-the-4-hit-process-in-the-pathogenesis-of-iga-nephropathy/29539/TBDManaging High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
https://reachmd.com/programs/frontlines-osteoporosis/managing-high-risk-osteoporosis-post-hoc-findings-on-abaloparatide/32345/Abaloparatide has been gaining attention as a treatment option for patients with osteoporosis at very high risk of fracture. A recent post-hoc analysis of the ACTIVE trial, which examined how abaloparatide compares to teriparatide and placebo in reducing fractures and improving bone mineral density,Cutera’s AviClear
https://reachmd.com/topics/energy-based-devices/cuteras-aviclear/35163/Visible Benefit of Compression for Leukocytoclastic Vasculitis
https://reachmd.com/programs/practical-dermatology/visible-benefit-of-compression-for-leukocytoclastic-vasculitis/24212/The use of compression stockings has been suggested in the management of leukocytoclastic vasculitis (LCV), however there are a lack of studies in the literature that provide evidence of the benefit of compression therapy in the treatment of LCV.1,2 Here we present a case that visually demonstratesA Clinician's Guide to the ACIP Travel Vaccination Recommendations
https://reachmd.com/programs/vaccination/a-clinicians-guide-to-the-acip-travel-vaccination-recommendations/26483/Get ready to integrate the latest ACIP updates into practice to improve patient care and public health outcomes with this essential recap.Make Filler Great Again
https://reachmd.com/ma-issues-index/2025-mar-apr/make-filler-great-again-restoring-balance-function-and-trust/36063/Restoring balance, function, and trustTargeting CKD-aP at the Source: Key Mechanisms and Treatments
https://reachmd.com/programs/cme/targeting-ckd-ap-at-the-source-key-mechanisms-and-treatments/37606/Explore CKD-associated pruritus mechanisms, clinical impact, and evidence-based treatments, including kappa-opioid receptor agonists.Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
https://reachmd.com/programs/cme/case-based-approach-managing-hyperkalemia-in-patients-with-ckd-and-heart-failure/37617/Explore expert tips on using potassium binders to manage hyperkalemia and maintain GDMT in patients with CKD and heart failure.DKA in Focus: What the New Consensus Means for Practice
https://reachmd.com/programs/cme/dka-new-consensus-practice/50979/If widespread use of continuous ketone monitoring (CKM) devices is to be safe and effective in reducing the occurrence of diabetic ketoacidosis (DKA), it is important to establish clear ketone thresholds which notify CKM users when action on their part is required. In preparation for availability anIBD in Focus: A Case-Based Approach to Diagnosis and Assessment
https://reachmd.com/programs/cme/ibd-in-focus-a-case-based-approach-to-diagnosis-and-assessment/49150/Discuss diagnostic evaluation and severity assessment in a case of suspected IBD using clinical, laboratory, endoscopic, and imaging data.